기관내 튜브 시장 규모는 2024년 15억 8,267만 달러에서 예측 기간 동안 연평균 4.09%의 CAGR로 2032년에는 21억 7,359만 달러 규모로 성장할 것으로 예상됩니다.
만성 호흡기질환 및 종양 질환의 유병률 증가, 수술 및 외상 사례의 증가는 기관내 튜브에 대한 수요를 촉진하고 있습니다. 또한, 항균 코팅 튜브와 주요 업체들의 개선된 디자인과 같은 혁신이 기관내 튜브의 채택을 촉진하고 있습니다. 이러한 요인들이 복합적으로 작용하여 기관내 튜브 세계 시장이 확대되고 있으며, 예측 기간 동안 시장 성장을 더욱 촉진하고 있습니다.
시장 역학:
세계 기관내 튜브 시장은 만성 호흡기질환의 유병률 증가, 암 환자 증가, 기술 발전에 힘입어 큰 폭의 성장세를 보이고 있습니다.
호주 보건 복지 연구소(Australian Institute of Health and Welfare)에 따르면(2022년) 호주 인구의 34%에 해당하는 약 850만 명이 만성 호흡기질환을 앓고 있는 것으로 추정됩니다. 전 세계적으로는 Global Burden of Disease(2023년)에 따르면, 20명 중 1명이 만성 호흡기질환을 앓고 있는 것으로 보고되고 있습니다. 이러한 질병은 종종 심각한 호흡 곤란을 유발하고 기도 관리를 포함한 빈번한 의료 개입을 필요로 합니다. 응급 상황에서는 적절한 산소 공급을 유지하기 위해 기계적 환기가 필수적이며 기관내 튜브는 이러한 절차의 주요 수단입니다. 오염, 흡연, 고령화 등의 요인으로 인해 전 세계적으로 호흡기질환의 발생률이 지속적으로 증가하고 있으며, 이는 기관내 튜브 시장의 수요를 촉진하고 있습니다.
이와 함께 전 세계 암 발병률의 증가는 시장 성장을 더욱 가속화하고 있으며, GLOBOCAN(2022)에 따르면 전 세계적으로 새로 발생한 암 환자는 약 2,000만 명으로 추산되며, 2045년에는 3,260만 명으로 증가할 것으로 예상됩니다. 많은 암 환자, 특히 호흡기 관련 수술을 받는 환자들은 삽관을 통한 기도 관리가 필요합니다. 예를 들어, 폐암 환자는 생검, 종양 절제술, 수술 후 관리 등의 과정에서 호흡곤란을 겪는 경우가 많으며, 이 모든 과정에서 기관내 튜브가 필요합니다. 또한 화학요법이나 방사선 치료와 같은 암 치료는 기도폐쇄, 호흡부전 등의 합병증을 유발할 수 있어 기계식 인공호흡기에 대한 수요를 더욱 증가시키고 있습니다.
2021년 11월, GE헬스케어는 기관내 튜브 삽입을 지원하기 위해 설계된 최초의 엑스레이 AI 솔루션인 GE헬스케어의 Critical Care Suite 2.0의 일부인 이 AI 툴은 업계 최초의 AI 알고리즘 모음으로, 자동 측정, 환자 우선순위 지정 및 품질 우선순위 지정이 가능합니다. 2.0의 일부인 이 AI 툴은 업계 최초로 모바일 엑스레이 장비에 통합된 AI 알고리즘 모음으로 자동 측정, 사례 우선순위 지정 및 품질 관리를 제공합니다. 이러한 혁신은 시술의 정확성을 높이고, 배치 오류를 줄이며, 환자 결과를 개선하고, 기관내 튜브의 채택률을 더욱 높일 수 있습니다.
이러한 성장 촉진요인에도 불구하고, 시장은 도전과제에 직면해 있습니다. 인공호흡기 관련 폐렴(VAP)의 위험과 함께 치아, 성대, 기관 손상 가능성을 포함한 삽입 시 합병증이 시장 성장에 걸림돌이 될 수 있습니다. 이러한 위험은 유해한 결과를 줄이기 위해 지속적인 교육, 기기 설계 개선, 안전 프로토콜 준수 등 지속적인 훈련의 필요성을 강조하고 있습니다.
세계의 기관내 튜브 시장을 조사했으며, 시장 개요, 시장 영향요인 및 시장 기회 분석, 시장 규제 환경, 시장 규모 추정 및 예측, 각종 부문별·지역별·주요 국가별 상세 분석, 경쟁 구도, 주요 기업 개요 등의 정보를 정리하여 전해드립니다.
Endotracheal Tube Market by Product Type (Standard, Reinforced, Coated, and Others), Cuff Type (Cuffed and Uncuffed/Cuffless), Intubation Route (Nasal, Oral, and Others), Age Group (Adult and Pediatric), End User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR forecast till 2032 owing to the increasing prevalence of chronic respiratory and oncological disorders, growing surgical procedures, rising number of trauma and accident cases, and increase in product development activities by key market players across the globe.
The endotracheal tubes market was valued at USD 1,582.67 million in 2024, growing at a CAGR of 4.09% during the forecast period from 2025 to 2032 to reach USD 2,173.59 million by 2032. The rising prevalence of chronic respiratory and oncological disorders, along with an increase in surgical procedures and trauma cases, is driving demand for endotracheal tubes. Additionally, innovations like antimicrobial-coated tubes and improved designs by key market players are boosting their adoption. Together, these factors are expanding the global market for endotracheal tubes further propelling the market growth during the forecast period from 2025 to 2032.
Endotracheal Tubes Market Dynamics:
The global endotracheal tubes market is poised for significant growth, driven by the increasing prevalence of chronic respiratory conditions, rising cancer cases, and technological advancements.
According to the Australian Institute of Health and Welfare (2022), approximately 8.5 million people, or 34% of Australia's population were estimated to have chronic respiratory conditions. On a global scale, the Global Burden of Disease (2023) reported that 1 in 20 individuals suffers from chronic respiratory diseases. These conditions often lead to severe breathing difficulties, necessitating frequent medical interventions that involve airway management. In critical scenarios, mechanical ventilation is essential to maintain proper oxygenation, with endotracheal tubes being a primary tool in such procedures. Factors like pollution, smoking, and aging populations continue to drive the global incidence of respiratory diseases, thereby fueling market demand for endotracheal tubes.
In parallel, the rising global burden of cancer further escalates market growth. As per GLOBOCAN (2022), there were an estimated 20 million new cancer cases globally, with projections indicating an increase to 32.6 million by 2045 . Many cancer patients particularly those undergoing respiratory-related surgeries require airway management through intubation. For instance, lung cancer patients often face breathing difficulties during procedures such as biopsies, tumor resections, and post-operative care, all of which necessitate endotracheal tubes. Additionally, cancer treatments like chemotherapy and radiation may cause complications such as airway obstruction or respiratory failure, further increasing the demand for mechanical ventilation devices.
Technological advancements are also playing a crucial role in propelling market growth. In November 2021, GE Healthcare received FDA clearance for the first X-ray artificial intelligence (AI) solution designed to assist in endotracheal tube placement. This AI tool, part of GE Healthcare's Critical Care Suite 2.0, is an industry-first collection of AI algorithms integrated into a mobile X-ray device, offering automated measurements, case prioritization, and quality control. Such innovations enhance procedural accuracy, reduce placement errors, and improve patient outcomes, further boosting adoption rates of endotracheal tubes.
Despite these growth drivers, the market faces challenges. Complications during insertion, including potential damage to teeth, vocal cords, or the trachea, along with the risk of ventilator-associated pneumonia (VAP), may hinder market expansion. These risks highlight the need for ongoing training, improved device designs, and adherence to safety protocols to mitigate adverse outcomes.
In conclusion, the interplay of rising chronic respiratory diseases, increasing cancer prevalence, and technological innovations is expected to drive the global endotracheal tube market. However, addressing procedural risks and infection control remains vital to sustain long-term growth.
Endotracheal Tubes Market Segment Analysis:
Endotracheal Tubes Market by Product Type (Standard, Reinforced, Coated, and Others), Cuff Type (Cuffed and Uncuffed/Cuffless), Intubation Route (Nasal, Oral, and Others), Age Group (Adult and Pediatric), End User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)
In the cuff type segment of the overall endotracheal tubes market, the cuffed endotracheal tubes are expected to hold the largest share in the year 2024. Cuffed endotracheal tubes are increasingly driving the growth of the endotracheal tube market due to their advanced design and substantial benefits in airway management. The primary advantage of cuffed endotracheal tubes lies in the cuff a balloon-like component that inflates once the tube is in place, creating a seal around the trachea. This seal is critical for ensuring that the airway remains secure, preventing air leaks, and reducing the risk of aspiration, which occurs when stomach contents enter the lungs. Additionally, cuffed endotracheal tubes allow for more precise control of ventilation pressures, which is crucial for patients requiring mechanical ventilation. The ability to adjust cuff pressure helps optimize ventilation and minimizes the risk of ventilator-associated pneumonia (VAP) by reducing the potential for contamination and infection. This is especially important in intensive care units (ICUs) and emergency settings where patients are at high risk for such infections.
The market for cuffed endotracheal tubes is further bolstered by ongoing innovations in cuff technology and materials. Modern cuff designs use advanced materials that are less prone to air leaks and are more comfortable for patients. These improvements contribute to better patient outcomes and higher safety standards, making cuffed tubes a preferred choice in many clinical scenarios thereby boosting the overall market of cuffed endotracheal tubes.
Hence, all the above-mentioned factors are expected to generate considerable revenue for the segment pushing the overall growth of the global endotracheal tubes market during the forecast period.
North America is expected to dominate the overall Endotracheal Tubes market:
Among all the regions, North America is expected to hold the largest share of the global endotracheal tubes market in 2024. The growing prevalence of chronic respiratory disorders and cancer cases, increased surgical procedures, and rising number of trauma and accident cases have boosted the overall market across the region. Additionally, recent product developmental activities such as product approval and launches are expected to aid in the growth of the North American endotracheal tubes market during the forecast period from 2025 to 2032.
As per the data provided by the Centre for Disease Control and Prevention (2024), in 2022, 4.6% of adults had been diagnosed with COPD, emphysema, or chronic bronchitis in the United States. COPD, emphysema, and chronic bronchitis cause severe breathing difficulties and frequent exacerbations, often requiring intubation and mechanical ventilation in advanced stages. Endotracheal tubes are essential for securing the airway and providing precise ventilation support for the patients thereby escalating the overall market across the region. Furthermore, as per the recent data and stats provided by the Centre for Disease Control and Prevention (2023), in 2022, the admission rate of mothers to an intensive care unit (ICU) during delivery hospitalization was 1.8 per 1,000 live births. The admission rate of mothers to an intensive care unit (ICU) can significantly boost the market for endotracheal tubes due to the critical need for airway management in severe obstetric complications. Conditions such as severe preeclampsia, postpartum hemorrhage, or complications during labor and delivery may necessitate emergency intubation and mechanical ventilation to ensure maternal safety and optimal respiratory support thereby boosting the overall market of endotracheal tubes.
According to the recent data and stats provided by the Centre for Disease Control and Prevention (2024), there were 24.8 million physician office visits and 25.5 million emergency department visits for unintentional road traffic injuries. Road traffic accidents often cause severe injuries that impair breathing, requiring immediate airway management. Endotracheal tubes are essential for securing the airway, ensuring proper ventilation, and preventing complications in emergency settings. The high frequency of such accidents drives demand for these tubes to manage critical airway needs efficiently.
Therefore, the interplay of the above-mentioned factors in the region is expected to boost the North America endotracheal tubes market during the forecast period.
Endotracheal Tubes Market Key Players:
Some of the key market players operating in the endotracheal Tubes market include Medtronic PLC, Smiths Medical, Teleflex Incorporated, VYAIRE MEDICAL, INC., Avanos Medical, Inc., ConvaTec, Inc., BACTIGUARD AB, Vygon, N8 Medical, LLC, Novo Klinik-Service GmbH, Intersurgical Ltd., Salter Labs (SunMed), Angiplast Pvt Ltd., Guangzhou Orcl Medical Co., Ltd., ROYAX, S.R.O, Sumi, HUM Gesellschaft fur Homecare und Medizintechnik mbH, MEDADV Medical, Van Oostveen Medical B.V., DEAS S.R.L, and others.
Recent Developmental Activities in the Endotracheal Tubes Market:
Key Takeaways from the Endotracheal Tubes Market Report Study:
Target Audience Who Can be Benefited from this Endotracheal Tubes Market Report Study:
Frequently Asked Questions for the Endotracheal Tubes Market: